Erectile Dysfunction (ED), also known as impotence, is the inability to maintain erection of the penis necessary for sexual intercourse. Erectile dysfunction is mostly related to neurologic, vascular, hormonal, and psychological disorders. The excessive use of drugs may also lead to erectile dysfunction in many cases. Erectile dysfunction treatments are used to cure patients and can be done through drugs or devices.
The Canada erectile dysfunction treatment market was valued at US$ 292.3 Mn in 2018 and is expected to reach US$ 430.5 Mn by the year 2026, growing at a significant CAGR during the forecast period. The Canada erectile dysfunction treatment market is mainly driven by the increasing awareness about erectile dysfunction, as well as the rising incidence of erectile dysfunction. Approximately, 50% of men between the age group of 40-70 years gets affected by erectile dysfunction. Advancements in the currently available treatment options are also driving the growth of the market.
The erectile dysfunction treatment market is segmented on the basis of treatment type and end-user. Based on the treatment type, the market is categorized as drugs and devices. Among these, the drugs segment dominated the market in the year 2018, with a market share of 91.9%. The drugs segment is expected to grow with a CAGR of 5.1% during the forecast period. There are various developments in erectile dysfunction drugs to cure the disease. The major drugs used for erectile dysfunction treatment include Sildenafil, Tadalafil, and Vardenafil.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key End-user
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approach Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation Scope
Chapter 2 Executive Summary
2.1 Market Summary
2.1.1 Canada Erectile Dysfunction Treatment Market, 2016-2026, (US$ Mn)
2.1 Market Snapshot: Canada Erectile Dysfunction Treatment Market
2.2 Market Dynamics
2.3 Canada Erectile Dysfunction Treatment Market, by Segment, 2018
2.3.1 Canada Erectile Dysfunction Treatment Market, by Treatment Type, 2018, (US$ Mn)
2.3.2 Canada Erectile Dysfunction Treatment Market, by End-user, 2018 (US$ Mn)
Chapter 3 Market Dynamics
3.1 Market Overview
3.2 Market Drivers
3.2.1 Increasing awareness about erectile dysfunction
3.2.1 Rising incidence of erectile dysfunction
3.3 Market Restraints
3.3.1 Social stigma associated with erectile dysfunction
3.4 Market Opportunities
3.4.1 Advancement in the treatment options for erectile dysfunction
3.5 Industry SWOT Analysis
Chapter 4 Canada Erectile Dysfunction Treatment Market, by Treatment Type
4.1 Market Overview, by Treatment Type
4.1.1 Canada Erectile Dysfunction Treatment Market, by Treatment Type, 2016-2026 (US$ Mn)
4.1.2 Incremental Opportunity, by Treatment Type, From 2018-2026
4.2 Drugs
4.2.1 Canada Erectile Dysfunction Treatment Market, by Drugs, 2016-2026, (US$ Mn)
4.3 Devices
4.3.1 Canada Erectile Dysfunction Treatment Market, by Devices, 2016-2026, (US$ Mn)
Chapter 5 Canada Erectile Dysfunction Treatment Market, by End-user
5.1 Market Overview, by End-user
5.1.1 Canada Erectile Dysfunction Treatment Market, by End-user, 2016-2026 (US$ Mn)
5.1.2 Incremental Opportunity, by End-user, From 2018-2026
5.2 Hospitals
5.2.1 Canada Erectile Dysfunction Treatment Market, by Hospitals, 2016-2026, (US$ Mn)
5.3 Speciality Clinics (ED Clinics)
5.3.1 Canada Erectile Dysfunction Treatment Market, by Speciality Clinics (ED Clinics), 2016-2026, (US$ Mn)
5.4 Others
5.4.1 Canada Erectile Dysfunction Treatment Market, by Others, 2016-2026, (US$ Mn)
Chapter 6 Competitive Intelligence
6.1 Market Players Present in Market Life Cycle
6.2 Top 5 Players Comparison
6.3 Market Positioning of Key Players, 2018
6.4 Market Players Mapping
6.4.1 By Treatment Type
6.4.2 By End-user
6.5 Strategies Adopted by Key Market Players
6.6 Recent Developments in the Market
6.6.1 Mergers & Acquisitions, Partnership, New Product Developments
6.7 Operational Efficiency Comparison by Key Players
Chapter 7 Company Profiles
7.1 Coloplast Group
7.1.1 Coloplast Group Overview
7.1.2 Key Stakeholders/Person in Coloplast Group
7.1.3 Coloplast Group Products Portfolio
7.1.4 Coloplast Group Financial Overview
7.1.5 Coloplast Group News/Recent Developments
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Overview
7.2.2 Key Stakeholders/Person in Boston Scientific Corporation
7.2.3 Boston Scientific Corporation Products Portfolio
7.2.4 Boston Scientific Corporation Financial Overview
7.2.5 Boston Scientific Corporation News/Recent Developments
7.3 Zephyr Surgical Implants SARL
7.3.1 Zephyr Surgical Implants SARL Overview
7.3.2 Key Stakeholders/Person in Zephyr Surgical Implants SARL
7.3.3 Zephyr Surgical Implants SARL Products Portfolio
7.3.4 Zephyr Surgical Implants SARL Financial Overview
7.3.5 Zephyr Surgical Implants SARL News/Recent Developments
7.4 Medispec
7.4.1 Medispec Overview
7.4.2 Key Stakeholders/Person in Medispec
7.4.3 Medispec Products Portfolio
7.4.4 Medispec Financial Overview
7.4.5 Medispec News/Recent Developments
7.5 KARL STORZ SE & Co. KG
7.5.1 KARL STORZ SE & Co. KG Overview
7.5.2 Key Stakeholders/Person in KARL STORZ SE & Co. KG
7.5.3 KARL STORZ SE & Co. KG Products Portfolio
7.5.4 KARL STORZ SE & Co. KG Financial Overview
7.5.5 KARL STORZ SE & Co. KG News/Recent Developments
7.6 Augusta Medical Systems LLC
7.6.1 Augusta Medical Systems LLC Overview
7.6.2 Key Stakeholders/Person in Augusta Medical Systems LLC
7.6.3 Augusta Medical Systems LLC Products Portfolio
7.6.4 Augusta Medical Systems LLC Financial Overview
7.6.5 Augusta Medical Systems LLC News/Recent Developments
TABLE 1 Market Snapshot: Canada Erectile Dysfunction Treatment Market Value
TABLE 2 Canada Erectile Dysfunction Treatment Market, by Treatment Type, 2016-2026
TABLE 3 Canada Erectile Dysfunction Treatment Market, by End-user, 2016-2026 (US$ Mn)
TABLE 4 Top 5 Players Comparison
TABLE 5 Top Players Market Mapping – By Treatment Type
TABLE 6 Top Players Market Mapping – By End-user
TABLE 7 Strategies Adopted by Key Market Players
TABLE 8 Mergers & Acquisitions, Partnership, New Product Developments
TABLE 9 Coloplast Group Overview
TABLE 10 Key Stakeholders/Person in Coloplast Group
TABLE 11 Coloplast Group Product Portfolio
TABLE 12 Coloplast Group News/Recent Developments
TABLE 13 Boston Scientific Corporation Overview
TABLE 14 Key Stakeholders/Person in Boston Scientific Corporation
TABLE 15 Boston Scientific Corporation Product Portfolio
TABLE 16 Boston Scientific Corporation News/Recent Developments
TABLE 17 Zephyr Surgical Implants SARL Overview
TABLE 18 Key Stakeholders/Person in Zephyr Surgical Implants SARL
TABLE 19 Zephyr Surgical Implants SARL Product Portfolio
TABLE 20 Zephyr Surgical Implants SARL News/Recent Developments
TABLE 21 Medispec Overview
TABLE 22 Key Stakeholders/Person in Medispec
TABLE 23 Medispec Product Portfolio
TABLE 24 Medispec News/Recent Developments
TABLE 25 KARL STORZ SE & Co. KG Overview
TABLE 26 Key Stakeholders/Person in KARL STORZ SE & Co. KG
TABLE 27 KARL STORZ SE & Co. KG Product Portfolio
TABLE 28 KARL STORZ SE & Co. KG News/Recent Developments
TABLE 29 Augusta Medical Systems LLC Overview
TABLE 30 Key Stakeholders/Person in Augusta Medical Systems LLC
TABLE 31 Augusta Medical Systems LLC Product Portfolio
TABLE 32 Augusta Medical Systems LLC News/Recent Developments